David Sellers Walton MD
Glaucoma Related, Pediatric & Strabismus
Instructor in Medicine, Brigham and Women's Hospital
Join to View Full Profile
8 Hawthorne PlSte 110Boston, MA 02114
Phone+1 617-227-3011
Fax+1 617-227-3011
Dr. Walton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts Eye and Ear/Harvard Medical SchoolResidency, Ophthalmology, 1965 - 1967
Boston Children’s Hospital/Boston Medical CenterInternship, Pediatrics, 1961 - 1962
Duke University School of MedicineClass of 1961
Certifications & Licensure
NJ State Medical License 1965 - Present
MA State Medical License 1964 - 2027
ME State Medical License Active through 2004
NC State Medical License 1961 - 1978
American Board of Ophthalmology Ophthalmology
American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Boston Magazine Castle Connolly, 2010-2013
- Fellow (FAAO) American Academy of Ophthalmology
Publications & Presentations
PubMed
- AAV-IKV mediated expression of decorin inhibits EMT and fibrosis in a murine model of Glaucoma and AAV-IKV transduction in Non-Human Primates.Pushpa Rao, Manish Mishra, Siobhan M Cashman, David S Walton, Rajendra Kumar-Singh
Scientific Reports. 2025-03-07 - Novel Intragenic and Genomic Variants Highlight the Phenotypic Variability in-Related Disease.Linda M Reis, Donald Basel, Pierre Bitoun, David S Walton, Tom Glaser
Genes. 2024-12-20 - 3 citationsCase report: Extending the spectrum of clinical and molecular findings in FOXC1 haploinsufficiency syndrome.Alexandra Garza Flores, Ida Nordgren, Maria Pettersson, Dora Dias-Santagata, Daniel Nilsson
Frontiers in Genetics. 2023-01-01
Press Mentions
Fera Pharma Pounces on Abandoned Pfizer Pediatric Glaucoma DrugAugust 10th, 2021- After Leaving Patients in Limbo, Pfizer Agrees to Sell a Discontinued Glaucoma DrugAugust 9th, 2021
- CT Teen Is Losing Her ‘Last Resort’ to Protect Her Eyes as Pfizer Discontinues Her MedicationMay 2nd, 2021
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
